申请人:NPS PHARMACEUTICALS, INC.
公开号:EP1203761A2
公开(公告)日:2002-05-08
The present invention features compounds of general formulae a), b), c), able to modulate one or more activities of an inorganic ion receptor and methods for treating diseases or disorders by modulating inorganic ion receptor activity. Preferably, the compound can mimic or block the effect of extracellular Ca2+ on a calcium receptor.
本发明的特征是通式 a)、b)、c)的化合物能够调节无机离子受体的一种或多种活性,以及通过调节无机离子受体活性来治疗疾病或失调的方法。优选地,化合物可以模拟或阻断细胞外 Ca2+ 对钙受体的影响。